Speakers

Expand/Collapse

Afam Okoye
Research Associate Professor, VGTI-Vaccine & Gene Therapy Institute
OHSU

Day One Morning

Wednesday May 25, 2022

8:30 am | Breakfast Panel: What does the Future Landscape of Vaccinology Look Like? How Can we Further Leverage mRNA Technology in Vaccinology & How Can Pharma & Biotech Prepare to Expand?

Amesh Adalja
Senior Scholar
John Hopkins Centre for Health Security

Day One Morning

Wednesday May 25, 2022

10:45 am | A Framework to Analyze the Pandemic Potential of Pathogens: COVID-19 & Future Directions

Ami Patel
Research Assistant Professor
The WISTAR Institute

Day One Morning

Wednesday May 25, 2022

1:45 pm | Optimizing DNA Vaccines Against Emerging Infectious Diseases

Andrew Geall
Chief Development Officer
Replicate Bio

Day One Morning

Wednesday May 25, 2022

2:15 pm | Next Generation Self-Replicating RNA Vectors to Enable New Approaches to Immunotherapy Synopsis

Anna Blakney
Assistant Professor
University of British Columbia

Day One Morning

Wednesday May 25, 2022

5:15 pm | Unravelling Viral & Non-viral Delivery Approaches for Next Generation RNA Therapeutics

Birgitte Giersing
Technical Officer, Initiative for Vaccine Reseach
World Health Organisation

Day Two

Thursday May 26, 2022

10:00 am | Establishment of a COVID-19 mRNA Vaccine Technology Transfer Hub to Scale Up Global Manufacturing

Bosco Paes
Professor Emeritus, Pediatrics
McMaster University

Day Two

Thursday May 26, 2022

4:00 pm | The Canadian Registry of Palivizumab (CARESS): Outcomes Following Twelve Seasons of RSV Prophylaxis

David Morrissey
Vice President & Head, RNA Incubator
Pfizer

Day One Morning

Wednesday May 25, 2022

8:00 am | Advancing Pfizer’s mRNA Strategy

Denis Vargo
Vice President, Head of Drug Safety & Pharmacovigilance
Akebia Therapeutics

Day One Morning

Wednesday May 25, 2022

8:30 am | Breakfast Panel: What does the Future Landscape of Vaccinology Look Like? How Can we Further Leverage mRNA Technology in Vaccinology & How Can Pharma & Biotech Prepare to Expand?

Don Diamond
Professor, Cancer & Viral Vaccines
City of Hope

Day Two

Thursday May 26, 2022

12:00 pm | Conception, Construction, Pre-Clinical & Clinical Testing of COH04S1 Vaccine with Activity Against SARS-CoV-2

Doug Holtzman
Chief Scientific Officer
ICOSAVAX

Day One Morning

Wednesday May 25, 2022

4:15 pm | A Novel Two-Component VLP Technology for the Development of Vaccines Against Respiratory Viruses

Pre-Conference Focus Day: Respiratory Infectious Disease Vaccine Development

Tuesday, May 24, 2022

4:00 pm | A Novel Two-Component VLP Technology for the Development of Vaccines Against Respiratory Viruses

Dushyant Varshney
Chief Technology Officer
Arcturus Therapeutics

Day Two

Thursday May 26, 2022

3:00 pm | Global Technology Transfer & Commercialization of Next-Gen mRNA Vaccines

Emma Thompson
Professor of Infectious Diseases
Centre for Virus Research, University of Glasgow

Day One Morning

Wednesday May 25, 2022

11:15 am | SARS-CoV-2 Genetic Variation and Vaccine Effectiveness

8:30 am | Breakfast Panel: What does the Future Landscape of Vaccinology Look Like? How Can we Further Leverage mRNA Technology in Vaccinology & How Can Pharma & Biotech Prepare to Expand?

Galit Alter
Professor of Medicine
Harvard Medical School

Day Two

Thursday May 26, 2022

11:30 am | Systems Serology to Define Updated Correlates of Immunity to SARS-CoV-2

Geeta Swamy
Associate Vice President for Research Vice Dean for Scientific Integrity Professor, Obstetrics & Gynecology
Duke University

Day Two

Thursday May 26, 2022

2:30 pm | Observational Maternal COVID-19 Vaccination Clinical Data

Grace Chen
Senior Director, Clinical Development
Moderna

Day One Morning

Wednesday May 25, 2022

2:45 pm | Clinical Updates of mRNA-1345, Moderna’s Prophylactic Vaccine for RSV

Hildegund Ertl
Professor
The WISTAR Institute

Day One Morning

Wednesday May 25, 2022

5:45 pm | Therapeutic HBV Vaccine to Target Internal Viral Proteins: Clinical Development

Ian Mitchell
Professor Emeritus, Department of Pediatrics
University of Calgary

Day Two

Thursday May 26, 2022

5:00 pm | The Burden of RSV Infection on Healthcare Systems, Children & Families

Jakob Cramer
Head of Clinical Development
CEPI

Day Two

Thursday May 26, 2022

9:00 am | Clinical & Operational Challenges of COVID-19 Vaccine Development & Future Opportunities

James Cody
Senior Manager, Business Development, Biologics Solutions
Charles River Labs

Day One Morning

Wednesday May 25, 2022

9:15 am | Overcoming Challenges in Genetic Vaccine Development – Manufacturing and Testing

Jason Coleman
Clinical Application Scientist Lead
Precision Nano Systems

Day One Morning

Wednesday May 25, 2022

3:15 pm | Scalable Manufacturing Platform for RNA-LNP Vaccine Development

Jesse Erasmus
Director of Virology
HDT Bio

Day One Morning

Wednesday May 25, 2022

4:45 pm | Replicating RNA as a Platform for Active or Passive Immunization Against Emerging Infectious

Joshua DiNapoli
Global Project Head, mRNA Platform Development
Sanofi Pasteur

Day One Morning

Wednesday May 25, 2022

8:30 am | Breakfast Panel: What does the Future Landscape of Vaccinology Look Like? How Can we Further Leverage mRNA Technology in Vaccinology & How Can Pharma & Biotech Prepare to Expand?

Kay Hunsberger
Director of Infrastructure for Biological Clinical Manufacturing,
Merck

Day One Morning

Wednesday May 25, 2022

8:30 am | Breakfast Panel: What does the Future Landscape of Vaccinology Look Like? How Can we Further Leverage mRNA Technology in Vaccinology & How Can Pharma & Biotech Prepare to Expand?

Day Two

Thursday May 26, 2022

8:30 am | Developing Vaccines at Pandemic Speed

Leonard Krilov
Chairman, Department of Pediatrics
NYU Long Island School of Medicine

Day Two

Thursday May 26, 2022

4:30 pm | Updated RSV Epidemiology of High-Risk Infants & Toddlers

Martin Friede
Coordinator, Initiative for Vaccine Research
World Health Organisation

Day Two

Thursday May 26, 2022

10:00 am | Establishment of a COVID-19 mRNA Vaccine Technology Transfer Hub to Scale Up Global Manufacturing

Nerea Zabaleta Lasarte
Postdoctoral Research Fellow Grousbeck Gene Therapy Center
Harvard Medical School

Day Two

Thursday May 26, 2022

9:30 am | Clinical Development of AAVCOVID: A Single Dose AAV-Based Vaccine for COVID-19

Richard Thwaites
Consultant Neonatologist
Portsmouth Hospital University

Day Two

Thursday May 26, 2022

11:00 am | Clinical Burden of Severe RSV Infection During the First 2 Years of Life

Rok Sekirnik
Head Process Development mRNA/ pDNA
BIA Separations

Day One Morning

Wednesday May 25, 2022

12:15 pm | Increasing Productivity of IVT Reaction Using At-Line Monitoring by HPLC Chromatography

Sanie Sesay
Global Director Clinical Development, Vaccines
Sanofi Pasteur

Day Two

Thursday May 26, 2022

2:00 pm | Developing a Live Attenuated RSV Vaccine for Infants Newborns & Toddlers

Pre-Conference Focus Day: Respiratory Infectious Disease Vaccine Development

Tuesday, May 24, 2022

11:00 am | Developing a Live Attenuated RSV Vaccine for Infants & Toddlers

Sean Sullivan
Executive Director
Arcturus Therapeutics

Day One Morning

Wednesday May 25, 2022

11:45 am | Pre-Clinical and Clinical Development of a Next-Generation mRNA COVID-19 Vaccine

Pre-Conference Focus Day: Respiratory Infectious Disease Vaccine Development

Tuesday, May 24, 2022

9:00 am | Pre-Clinical Development of a Next-Generation mRNA Vaccine for Influenza

Simon van Haren
Research Associate, Division of Infectious Diseases, Precision Vaccines Program
Boston Children’s Hospital

Day Two

Thursday May 26, 2022

12:30 pm | Exploring Vaccine Adjuvant R&D Within RSV Models